0000904454-18-000629.txt : 20181002
0000904454-18-000629.hdr.sgml : 20181002
20181002185230
ACCESSION NUMBER: 0000904454-18-000629
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180924
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Forrester Robert
CENTRAL INDEX KEY: 0001319890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 181103113
MAIL ADDRESS:
STREET 1: C/O COMBINATORX, INCORPORATED
STREET 2: 245 FIRST STREET, 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-09-24
0001526119
Verastem, Inc.
VSTM
0001319890
Forrester Robert
C/O VERASTEM, INC.
117 KENDRICK STREET, SUITE 500
NEEDHAM
MA
02494
1
1
0
0
President and CEO
Common Stock
2018-09-28
4
P
0
2000
7.00
A
221234
D
Common Stock
5000
I
By trust
Common Stock
5000
I
By trust
Stock Option (Right to Buy)
2.97
2018-09-24
4
A
0
60000
0
A
2018-09-24
2028-01-05
Common Stock
60000
60000
D
Shares held by The Claudia Forrester 2001 Trust, the beneficiary of which is Claudia Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Shares held by The Iona Forrester 2001 Trust, the beneficiary of which is Iona Forrester, the Reporting Person's daughter. The Reporting Person is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
On January 5, 2018, the Reporting Person was granted an option to purchase 150,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 30,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 60,000 shares.
/s/ Joseph Chiapponi, Attorney-in-Fact
2018-10-02